Perceptive Advisors - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 69 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$2,648,000
-53.9%
750,000
-4.8%
0.08%
-7.2%
Q3 2021$5,743,000
-63.6%
787,745
-50.0%
0.08%
-19.4%
Q2 2021$15,786,000
+109.8%
1,575,490
+100.0%
0.10%
+8.4%
Q1 2021$7,523,000
-12.9%
787,7450.0%0.10%
+2.2%
Q4 2020$8,642,000
+23.7%
787,7450.0%0.09%
-8.8%
Q3 2020$6,987,000787,7450.10%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$9,963,0001.79%
Pentwater Capital Management LP 4,967,227$47,437,0000.45%
Boxer Capital, LLC 1,251,055$11,948,0000.40%
KNOTT DAVID M 29,566$282,0000.12%
Perceptive Advisors 787,745$7,523,0000.10%
Advisory Services Network, LLC 256,771$2,452,0000.09%
PURA VIDA INVESTMENTS, LLC 236,311$2,257,0000.06%
Rock Springs Capital Management LP 289,754$2,767,0000.06%
ALGERT GLOBAL LLC 19,410$185,0000.06%
Regent Investment Management LLC 23,000$220,0000.06%
View complete list of POSEIDA THERAPEUTICS INC shareholders